ApoE promotes the proteolytic degradation of Aβ

被引:738
作者
Jiang, Qingguang [1 ]
Lee, C. Y. Daniel [1 ]
Mandrekar, Shweta [1 ]
Wilkinson, Brandy [1 ]
Cramer, Paige [1 ]
Zelcer, Noam [2 ]
Mann, Karen [3 ]
Lamb, Bruce [3 ]
Willson, Timothy M. [4 ]
Collins, Jon L. [4 ]
Richardson, Jill C. [5 ]
Smith, Jonathan D. [6 ]
Comery, Thomas A. [7 ]
Riddell, David [7 ]
Holtzman, David M. [8 ]
Tontonoz, Peter [2 ]
Landreth, Gary E. [1 ]
机构
[1] Case Western Reserve Univ, Sch Med, Dept Neurosci, Alzheimers Res Lab, Cleveland, OH 44106 USA
[2] Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA
[3] Cleveland Clin Fdn, Lerner Res Inst, Dept Neurosci, Cleveland, OH 44195 USA
[4] GlaxoSmithKline, Discovery Res, Res Triangle Pk, NC 27709 USA
[5] GlaxoSmithKline, Harlow CM19 5AW, Essex, England
[6] Cleveland Clin Fdn, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44195 USA
[7] Wyeth Ayerst Res, Discovery Neurosci, Princeton, NJ 08543 USA
[8] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA
关键词
D O I
10.1016/j.neuron.2008.04.010
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Apolipoprotein E is associated with age-related risk for Alzheimer's disease and plays critical roles in A beta homeostasis. We report that ApoE plays a role in facilitating the proteolytic clearance of soluble A beta from the brain. The endolytic degradation of A beta peptides within microglia by neprilysin and related enzymes is dramatically enhanced by ApoE. Similarly, A beta degradation extracellularly by insulin-degrading enzyme is facilitated by ApoE. The capacity of Apo to promote A beta degradation is dependent upon the ApoE isoform and its lipidation status. The enhanced expression of lipidated ApoE, through the activation of liver X receptors, stimulates A beta degradation. Indeed, aged Tg2576 mice treated with the LXR agonist GW3965 exhibited a dramatic reduction in brain A beta load. GW3965 treatment also reversed contextual memory deficits. These data demonstrate a mechanism through which ApoE facilitates the clearance of A beta from the brain and suggest that LXR agonists may represent a novel therapy for A beta.
引用
收藏
页码:681 / 693
页数:13
相关论文
共 70 条
[1]   Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition [J].
Bales, KR ;
Verina, T ;
Dodel, RC ;
Du, YS ;
Altstiel, L ;
Bender, M ;
Hyslop, P ;
Johnstone, EM ;
Little, SP ;
Cummins, DJ ;
Piccardo, P ;
Ghetti, B ;
Paul, SM .
NATURE GENETICS, 1997, 17 (03) :263-264
[2]   Human amyloid-β synthesis and clearance rates as measured in cerebrospinal fluid in vivo [J].
Bateman, Randall J. ;
Munsell, Ling Y. ;
Morris, John C. ;
Swarm, Robert ;
Yarasheski, Kevin E. ;
Holtzman, David M. .
NATURE MEDICINE, 2006, 12 (07) :856-861
[3]   Nuclear receptors in lipid metabolism: Targeting the heart of dyslipidemia [J].
Beaven, SW ;
Tontonoz, P .
ANNUAL REVIEW OF MEDICINE, 2006, 57 :313-329
[4]   Transport pathways for clearance of human Alzheimer's amyloid β-peptide and apolipoproteins E and J in the mouse central nervous system [J].
Bell, Robert D. ;
Sagare, Abhay P. ;
Friedman, Alan E. ;
Bedi, Gurrinder S. ;
Holtzman, David M. ;
Deane, Rashid ;
Zlokovic, Berislav V. .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2007, 27 (05) :909-918
[5]   The effects of ABCA1 on cholesterol efflux and Aβ levels in vitro and in vivo [J].
Burns, Mark P. ;
Vardanian, Lilit ;
Pajoohesh-Ganji, Ahdeah ;
Wang, Lili ;
Cooper, Matthew ;
Harris, Donnie C. ;
Duff, Karen ;
Rebeck, G. William .
JOURNAL OF NEUROCHEMISTRY, 2006, 98 (03) :792-800
[6]   Liver X receptor-mediated gene regulation and cholesterol homeostasis in brain: Relevance to Alzheimer's disease therapeutics [J].
Cao, Guoqing ;
Bales, Kelly R. ;
DeMattos, Ronald B. ;
Paul, Steven M. .
CURRENT ALZHEIMER RESEARCH, 2007, 4 (02) :179-184
[7]   Acute γ-secretase inhibition improves contextual fear conditioning in the Tg2576 mouse model of Alzheimer's disease [J].
Comery, TA ;
Martone, RL ;
Aschmies, S ;
Atchison, KP ;
Diamantidis, G ;
Gong, XH ;
Zhou, H ;
Kreft, AF ;
Pangalos, MN ;
Sonnenberg-Reines, J ;
Jacobsen, JS ;
Marquis, KL .
JOURNAL OF NEUROSCIENCE, 2005, 25 (39) :8898-8902
[8]   LRP/amyloid β-peptide interaction mediates differential brain efflux of Aβ isoforms [J].
Deane, R ;
Wu, ZH ;
Sagare, A ;
Davis, J ;
Yan, SD ;
Hamm, K ;
Xu, F ;
Parisi, M ;
LaRue, B ;
Hu, HW ;
Spijkers, P ;
Guo, H ;
Song, XM ;
Lenting, PJ ;
Van Nostrand, WE ;
Zlokovic, BV .
NEURON, 2004, 43 (03) :333-344
[9]   ApoE and clusterin cooperatively suppress Aβ levels and deposition:: Evidence that ApoE regulates extracellular Aβ metabolism in vivo [J].
DeMattos, RB ;
Cirrito, JR ;
Parsadanian, M ;
May, PC ;
O'Dell, MA ;
Taylor, JW ;
Harmony, JAK ;
Aronow, BJ ;
Bales, KR ;
Paul, SM ;
Holtzman, DM .
NEURON, 2004, 41 (02) :193-202
[10]   Molecular and cellular physiology of apolipoprotein A-I lipidation by the ATP-binding cassette transporter A1 (ABCA1) [J].
Denis, M ;
Haidar, B ;
Marcil, M ;
Bouvier, M ;
Krimbou, L ;
Genest, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (09) :7384-7394